Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome

Pablo Rodriguez‐Viciana(Cancer Research Institute), Osamu Tetsu(Cancer Research Institute), William E. Tidyman(Cancer Research Institute), Anne L. Estep(Cancer Research Institute), Brenda A. Conger(Cancer Research Institute), Molly Santa Cruz(Cancer Research Institute), Frank McCormick(Cancer Research Institute), Katherine A. Rauen(Cancer Research Institute)
Science
January 26, 2006
Cited by 570

Abstract

Cardio-facio-cutaneous (CFC) syndrome is a sporadic developmental disorder involving characteristic craniofacial features, cardiac defects, ectodermal abnormalities, and developmental delay. We demonstrate that heterogeneous de novo missense mutations in three genes within the mitogen-activated protein kinase (MAPK) pathway cause CFC syndrome. The majority of cases (18 out of 23) are caused by mutations in BRAF, a gene frequently mutated in cancer. Of the 11 mutations identified, two result in amino acid substitutions that occur in tumors, but most are unique and suggest previously unknown mechanisms of B-Raf activation. Furthermore, three of five individuals without BRAF mutations had missense mutations in either MEK1 or MEK2, downstream effectors of B-Raf. Our findings highlight the involvement of the MAPK pathway in human development and will provide a molecular diagnosis of CFC syndrome.


Related Papers

No related papers found

Powered by citation graph analysis